Ortho Regenerative Technologies earned extensions of expiry dates on certain warrants.
Here are three observations:
1. The warrants were issued with private placements that closed prior to Ortho RTi's shares being listed.
2. An aggregate of 2.11 million warrants earned extensions. They were originally scheduled to expire throughout 2018 and 2019.
3. The extension is for an added year from their respective maturity dates. All other terms of the extended warrants remain unchanged.